The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women.
Study Design
- Тип исследования
- Case-control
- Размер выборки
- 100
- Вмешательство
- The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. None
- Препарат сравнения
- Placebo
- Направление эффекта
- Negative
- Риск систематической ошибки
- Moderate
Abstract
Objective We designed this study to evaluate the association of serum ferritin levels with non-scarring alopecia in women. Methodology All patients were diagnosed by performing a clinical examination of the crown part width and occiput. Ludwig's classification was used to categorize the cases into grades I-III. Different laboratory tests were performed for the baseline investigation, including serum iron, total iron-binding capacity (TIBC), hemogram, and thyroid function tests. Of the 5 ml of venous blood drawn for routine biochemical tests, 3 ml was stored at -20°C for measuring serum ferritin, while the other 2 ml was sent for a complete blood count. Student's t-test, a chi-square test, and Fisher's exact test were used for comparing the variables. Results This study recruited 100 cases of alopecia. Out of them, 46% of patients were diagnosed with alopecia areata, 25% of cases reported androgenetic alopecia, and 29% of cases of telogen effluvium were also observed. We observed overall mean serum ferritin levels of 20.47±17.50 and 27.87±17.51 in the case versus the control group with a statistically significant difference of 0.005. Conclusion Our study shows that iron stores are one of the independent hazards of alopecia in non-menopausal women. Thus, proper laboratory examination is needed to manage the disease prevalence and prognosis.
Full Text
Tables
Table 1
| Variables | Controls | Cases | P-value |
| Red cells | |||
| Erythrocyte sedimentation rate | 9.3±3.23 | 10.3±4.4 | 0.067 |
| Total erythrocyte count | 4.19±0.46 | 4.21±0.50 | 0.748 |
| Mean corpuscular hemoglobin (MCH) in picogram | 30.25±1.56 | 28.85±2.27 | 0.001 |
| Hemoglobin (HB) | 12.84±0.96 | 12.39±1.40 | 0.011 |
| Hematocrit (%) | 40.92±2.65 | 38.95±4.18 | 0.001 |
| Mean corpuscular hemoglobin concentration (MCHC) (g/dl) | 31.81±1.57 | 31.35±1.80 | 0.072 |
| Mean corpuscular volume (MCV) | 90.81±1.79 | 88.67±4.15 | 0.001 |
| Peripheral blood film | |||
| Abnormal (<15%) | 19% | 37% | 0.001 |
| Normal (>15%) | 81% | 63% | 0.001 |
Table 2
| Variables | N (%) | Mean±SD | P-value |
| Androgenetic alopecia | 25 (25%) | 15.23±9.27 | 0.015 |
| Grade I androgenetic alopecia | 16 (64%) | 16.86±11.33 | 0.011 |
| Grade II androgenetic alopecia | 9 (36%) | 13.59±7.73 | 0.017 |
| Alopecia areata | 46 (46%) | 19.71±18.56 | 0.017 |
| Telogen effluvium | 29 (29%) | 24.13±19.75 | 0.328 |
| Chronic telogen effluvium | 9 (31.03%) | 21.86±27.76 | 0.346 |
| Acute telogen effluvium | 20 (68.9%) | 27.57±16.89 | 0.945 |
Table 3
| Parameters | Case, N (%) | Controls, N (%) | P-value |
| <20 ng/ml | 63 (63%) | 38 (38%) | 0.001 |
| >20 ng/ml | 37 (37%) | 62 (62%) |
Table 4
| Subgroup | Serum ferritin of <20 ng/ml, N (%) | Serum ferritin of >20 ng/ml, N (%) | P-value |
| Androgenetic alopecia | 17 (68%) | 8 (32%) | 0.012 |
| Total cases of telogen effluvium | 16 (55.2%) | 13 (44.8%) | 0.990 |
| Chronic telogen effluvium | 7 (77.8%) | 2 (22.2%) | 0.031 |
| Acute telogen effluvium | 9 (45%) | 11 (55%) | 0.558 |
| Alopecia areata | 30 (65.2%) | 16 (34.8%) | 0.002 |
References
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
The Journal of investigative dermatology · 2003
Decreased serum ferritin is associated with alopecia in women.
Pediatrics · 2012
The diet factor in attention-deficit/hyperactivity disorder.
Journal of clinical and diagnostic research : JCDR · 2015
Telogen Effluvium: A Review.
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
Sleep medicine clinics · 2015